Rapid Regulation of P-Glycoprotein at the Blood-Brain Barrier by Endothelin-1
Open Access
- 1 September 2004
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 66 (3) , 387-394
- https://doi.org/10.1124/mol.104.001503
Abstract
The ATP-driven xenobiotic transporter P-glycoprotein is a critical element of the blood-brain barrier. To study regulation of P-glycoprotein function, we measured specific transport [(3′-oxo-4-butenyl-4-methyl-threonine(1), (valine(2)) cyclosporin (PSC833)-sensitive] of the fluorescent cyclosporin A derivative [N-ϵ(4-nitrobenzofurazan-7-yl)-d-Lys8]-cyclosporin A (NBDL-CSA) into the lumens of isolated rat brain capillaries using confocal microscopy and quantitative image analysis. Luminal NBDL-CSA accumulation was rapidly and reversibly reduced in a concentration-dependent manner by 0.1 to 100 nM endothelin-1 (ET-1). In this concentration range, ET-1 did not affect junctional permeability. The ETB receptor agonist sarafotoxin 6c also reduced transport. An ETB receptor antagonist blocked effects of ET-1 and sarafotoxin 6c; an ETA receptor antagonist was without effect. Consistent with this, immunostaining and Western blotting showed expression of the ETB receptor in brain capillary membranes. NBDL-CSA transport was also reduced by sodium nitroprusside, a NO donor, and by phorbol ester, a protein kinase C (PKC) activator. Inhibition of NO synthase (NOS) or PKC abolished the ET-1 effects. Thus, ET-1, acting through an ETB receptor, NOS, and PKC rapidly and reversibly reduced transport mediated by P-glycoprotein at the blood-brain barrier.Keywords
This publication has 27 references indexed in Scilit:
- Focal Lesions in the Rat Central Nervous System Induced by Endothelin-1Journal of Neuropathology and Experimental Neurology, 2003
- Alkylglycerol opening of the blood–brain barrier to small and large fluorescence markers in normal and C6 glioma‐bearing rats and isolated rat brain capillariesBritish Journal of Pharmacology, 2003
- Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxinBritish Journal of Pharmacology, 2003
- Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivoJournal of Clinical Investigation, 2002
- HIV-1-induced production of endothelin-1 in an in vitro model of the human blood???brain barrierNeuroReport, 2002
- A new multidrug resistance protein at the blood–brain barrierBiochemical and Biophysical Research Communications, 2002
- Trafficking of Canalicular ABC Transporters in HepatocytesAnnual Review of Physiology, 2002
- Endothelin System: The Double-Edged Sword in Health and DiseaseAnnual Review of Pharmacology and Toxicology, 2001
- Pathophysiological Role of Endothelin and Potential Therapeutic Targets for Receptor AntagonistsPublished by Springer Nature ,1998
- EndothelinsNew England Journal of Medicine, 1995